Clinical Trials

Showing trials with last updates posted in 2025.

NCT03811769 | TERMINATED | NA
335 participants

Large Stroke Therapy Evaluation

Study Type:
INTERVENTIONAL
Last Updated:
2025-09-29
Start Date:
2019-04-07
Completion:
2023-04-26
Conditions
  • Stroke
Interventions
  • OTHER
  • PROCEDURE
No Results Yet
NCT03547947 | ACTIVE_NOT_RECRUITING
200 participants

Clinical and Radiological Outcomes of Medacta Shoulder System

Study Type:
OBSERVATIONAL
Last Updated:
2025-09-29
Start Date:
2018-06-13
Completion:
2031-04-30
Conditions
  • Primary Osteoarthritis
  • Secondary Osteoarthritis
  • Rotator Cuff Tear Arthropathy
  • Rheumatoid Arthritis Shoulder
  • Avascular Necrosis
  • Fracture
  • Revision of Shoulder Arthroplasty
Interventions
  • DEVICE
No Results Yet
NCT03284346 | TERMINATED | NA
23 participants

Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors

Study Type:
INTERVENTIONAL
Last Updated:
2025-09-29
Start Date:
2017-08-17
Completion:
2019-07-15
Conditions
  • Cancer Survivor
  • No Evidence of Disease
  • Obesity
  • Overweight
  • Prostate Carcinoma
  • Sedentary Lifestyle
  • Stage I Breast Cancer
  • Stage IA Breast Cancer
  • Stage IB Breast Cancer
  • Stage II Breast Cancer
  • Stage IIA Breast Cancer
  • Stage IIB Breast Cancer
  • Stage III Breast Cancer
  • Stage IIIA Breast Cancer
  • Stage IIIB Breast Cancer
  • Stage IIIC Breast Cancer
Interventions
  • BEHAVIORAL
  • OTHER
No Results Yet
NCT03147885 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
43 participants

Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2025-09-29
Start Date:
2017-06-20
Completion:
2027-12-31
Conditions
  • Diffuse Large B-Cell Lymphoma
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • Recurrent Extranodal Marginal Zone Lymphoma
  • Recurrent Follicular Lymphoma
  • Recurrent Indolent Adult Non-Hodgkin Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Recurrent Marginal Zone Lymphoma
  • Recurrent Waldenstrom Macroglobulinemia
  • Refractory B-Cell Non-Hodgkin Lymphoma
  • Refractory Extranodal Marginal Zone Lymphoma
  • Refractory Follicular Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Stage III Non-Hodgkin Lymphoma
  • Stage IV Non-Hodgkin Lymphoma
  • Transformed Recurrent Non-Hodgkin Lymphoma
Interventions
  • DRUG
No Results Yet
NCT03015896 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
36 participants

Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2025-09-29
Start Date:
2017-02-14
Completion:
2026-08-09
Conditions
  • Grade 3a Follicular Lymphoma
  • Recurrent Burkitt Lymphoma
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent Follicular Lymphoma
  • Recurrent Grade 1 Follicular Lymphoma
  • Recurrent Grade 2 Follicular Lymphoma
  • Recurrent Lymphoplasmacytic Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Recurrent Marginal Zone Lymphoma
  • Recurrent Waldenstrom Macroglobulinemia
  • Refractory Burkitt Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory Follicular Lymphoma
  • Refractory Lymphoplasmacytic Lymphoma
  • Refractory Mantle Cell Lymphoma
Interventions
  • OTHER
  • DRUG
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page